Archive - The Century of Biology

Hub-and-Spoke Biotechs: Nimbus Therapeutics

Building an "evergreen" drug discovery engine

Oct 20 •

Elliot Hershberg

September 2024

Living Carbon: Photosynthesis-Enhanced Trees

Why and how to engineer trees; climate biotech business strategy

Sep 22 •

Elliot Hershberg

June 2024

A Summer Hiatus

Pausing before scaling

Jun 23 •

Elliot Hershberg

Scaling CRISPR Cures

Realizing the potential of genetic medicine

Jun 2 •

Elliot Hershberg

May 2024

Generating (Somewhat) New Biology with AI

Using protein language models for Digital Evolution

May 5 •

Elliot Hershberg

April 2024

Compounding Until Inflection

Present vs. future platform value

Apr 14 •

Elliot Hershberg

March 2024

Beyond Steel Tanks

GLP-1 drugs could one day outsell iPhones, but there is not enough biomanufacturing capacity to make them. For solutions, we should look away from the…

Published on Asimov Press • Mar 24

February 2024

New tools for programming biology

Continuous mutagenesis, RNA writing, and more

Feb 18 •

Elliot Hershberg

January 2024

December 2023

Colonizing Mars isn't a rocket problem

It's a biology problem

Dec 3, 2023 •

Elliot Hershberg

November 2023

On biotech platform strategy

Thoughts and updates on platform typology and partnering dynamics

Nov 12, 2023 •

Elliot Hershberg

and

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts